Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study

PURPOSE: We aimed to evaluate the long-term outcomes of concurrent chemoradiotherapy (CCRT) with a simultaneous integrated boost (SIB) of radiotherapy for esophageal squamous cell carcinoma (ESCC). METHODS AND MATERIALS: Eighty-seven patients with primary ESCC enrolled in this phase II trial. The ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chuangzhen, Chen, Jianzhou, Luo, Ting, Wang, Siyan, Guo, Hong, Zeng, Chengbing, Wu, Yanxuan, Liu, Weitong, Huang, Ruihong, Zhai, Tiantian, Chen, Zhijian, Li, Derui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639085/
https://www.ncbi.nlm.nih.gov/pubmed/34868933
http://dx.doi.org/10.3389/fonc.2021.738936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639085/
https://www.ncbi.nlm.nih.gov/pubmed/34868933
http://dx.doi.org/10.3389/fonc.2021.738936

Ejemplares similares